Abstract:Objective To analyze and determine the clinical, molecular pathology and genetic features of a Chinese family with dystrophinopathy. Methods Clinical data of the proband and his family members were collected. Immunohistochemistry staining was performed on muscular biopsy tissues with antimerosin, emerin and the N, C and central rod domains of dystrophin. Genomic DNA was extracted using standard procedures from the peripheral blood leukocytes. Multiplex ligation-dependent probe amplification (MLPA) was used to test Duchenne muscular dystrophy (DMD) gene to determine the ways and sites of genetic mutation, and analyze the relationships between genotype and phenotype. Results Patients from this family were clinically diagnosed as muscular dystrophy, and they presented serious manifestations although the immunohistochemistry analysis for the proband exhibited partial loss of dystrophin staining, and positive expression with merosin and emerin. Further test with MLPA detected the loss of exons 45--54 in DMD gene in the proband, while his mother had heterozygositic loss in exons 45--54. Conclusions The losses of exons 45--54 in the proband are all derived from his mother, who carries genetic mutation with normal phenotype. He has been diagnosed as dystrophinopathy. At the same time, his partial loss of dystrophin is not parallel to the out-of-frame mutation of the gene and his severe clinical manifestations. Abnormal expression of dystrophin is the pathological basis for dystrophinopathy phenotype. Its clinical outcome depends not only on the degree of the protein expression, but also on the function of the sites where the DMD gene less occurs. Key words: Muscular dystrophy, duchenne; Dystrophin; Pedigree; Biopsy; lmmunohistochemistry; Nucleic acid probes

[Clinical and Genetic Analysis of Three Pedigrees Affected with Myotonic Dystrophy].

Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1

[Clinical and genetic analysis of a pedigree of myotonic dystrophy disease].

DNA Analysis of a Pedigree with Myotonic Dystrophy in Songjiang County, Shanghai.

Teaching NeuroImages: Myotonic Dystrophy Type 1

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

Clinical and Pathological Analysis of 6 Patients with Myotonic Dystrophy

A Case Report of Myotonic Dystrophy Type 1 Presenting as Acute Respiratory Failure

[Application of triplet-primer PCR technology for the genetic testing and prenatal diagnosis of patients with Myotonic dystrophy type 1]

[Clinical, Molecular Pathological and Genetic Analyses of a Chinese Family with Congenital Muscular Dystrophy Type 1A].

[Genetic Analysis of a Chinese Pedigree Affected with Becker Muscular Dystrophy with Myalgia As the Main Feature].

Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

Studies of the Haplotypes of CTG Triplet Repeat and Alu±1kb in DMPK Gene of Myotonic Dystrophy

Retrospective Analysis of 97 Patients with Myotonic Dystrophy

CLINICAL AND PATHOLOGIC FEATURES OF A DISTAL MYOPATHY FAMILY

Latent factors underlying the symptoms of adult-onset myotonic dystrophy type 1 during the clinical course

Clinical, Molecular Pathological and Genetic Analysis of a Chinese Family with Dystrophinopathy